8Maertens J,Theunissen K B oogaererts M.Invasive aspergillosis:focus on new therapeutic agents[J].Curr Med Chen Anti-infective Agents 2002,1:65-81.
9Vermes A,Guchelaar HJ,Dankert J.Flucytosine:a review of its pharmacology,clinical indications,pharmacokinetics,toxicity and drug interactions[J].J Antimicrob Chemother 2000,6:171-179.
3Kami M, Kishi Y, Hamaki T, et al. The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis : an autopsy based retrospective study of 48 patients. Mycoses ,2002, 45:287-294.
4Pazos C, Ponton J, Palocio AD. Contribution of( 1-3 )-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neurpenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol,2005 ,43 :299-305.
5Odabnsi Z, Mattiuzzi G,Estey E,et al. β-D-glucan as a diagnostic adjunct for invasive fungal infections : validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis,2004,39:199-205.
6Picketing J-W, Sant HW, Bowles CA, et al. Evaluation of a( 1-3 )-β-D- glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol, 2005,43 : 5957 -5962.
8Zeichner LO, Alexander BD, Kett DH,et al. Multicenter clinical evaluation of the(1-3)-β-D-glucan assay as an aid to diagnosis of fungal infections in humuan. Clin Infect Dis,2005,41:654-659.
9Maertens J, Verhaegen J, Lagrou K,et al. Screening for circulating galactomannan as a nonlnvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood,2001,97 : 1604-1610.
10Pfeiffer CD,Fine JP,Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay:a meta-analysis. Clin Infect Dis,2006,42 : 1417- 727.
9Shimamoto A,Takao M, Shomura S,et al. Pulmonary histoplasmosis as an example of imported mycoses in Japan[J]. Gen Thorac Cardiovasc Surg, 2007,55(8) : 335-338.
